146 related articles for article (PubMed ID: 25940629)
1. NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning.
Setoain J; Franch M; Martínez M; Tabas-Madrid D; Sorzano CO; Bakker A; Gonzalez-Couto E; Elvira J; Pascual-Montano A
Nucleic Acids Res; 2015 Jul; 43(W1):W193-9. PubMed ID: 25940629
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
3. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
[TBL] [Abstract][Full Text] [Related]
4. Mantra 2.0: an online collaborative resource for drug mode of action and repurposing by network analysis.
Carrella D; Napolitano F; Rispoli R; Miglietta M; Carissimo A; Cutillo L; Sirci F; Gregoretti F; Di Bernardo D
Bioinformatics; 2014 Jun; 30(12):1787-8. PubMed ID: 24558125
[TBL] [Abstract][Full Text] [Related]
5. Proteogenomics Dashboard for the Human Proteome Project.
Tabas-Madrid D; Alves-Cruzeiro J; Segura V; Guruceaga E; Vialas V; Prieto G; García C; Corrales FJ; Albar JP; Pascual-Montano A
J Proteome Res; 2015 Sep; 14(9):3738-49. PubMed ID: 26144527
[TBL] [Abstract][Full Text] [Related]
6. eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs.
Brylinski M; Naderi M; Govindaraj RG; Lemoine J
J Mol Biol; 2018 Jul; 430(15):2266-2273. PubMed ID: 29237557
[TBL] [Abstract][Full Text] [Related]
7. Accurate Drug Repositioning through Non-tissue-Specific Core Signatures from Cancer Transcriptomes.
Xu C; Ai D; Shi D; Suo S; Chen X; Yan Y; Cao Y; Zhang R; Sun N; Chen W; McDermott J; Zhang S; Zeng Y; Han JJ
Cell Rep; 2018 Oct; 25(2):523-535.e5. PubMed ID: 30304690
[TBL] [Abstract][Full Text] [Related]
8. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics.
Tabas-Madrid D; Nogales-Cadenas R; Pascual-Montano A
Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W478-83. PubMed ID: 22573175
[TBL] [Abstract][Full Text] [Related]
9. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
Kwon OS; Kim W; Cha HJ; Lee H
Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
[TBL] [Abstract][Full Text] [Related]
10. GDA, a web-based tool for Genomics and Drugs integrated analysis.
Caroli J; Sorrentino G; Forcato M; Del Sal G; Bicciato S
Nucleic Acids Res; 2018 Jul; 46(W1):W148-W156. PubMed ID: 29800349
[TBL] [Abstract][Full Text] [Related]
11. From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures.
Namba S; Iwata M; Yamanishi Y
Bioinformatics; 2022 Jun; 38(Suppl 1):i68-i76. PubMed ID: 35758779
[TBL] [Abstract][Full Text] [Related]
12. Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases.
Liu Z; Fang H; Slikker W; Tong W
Trends Pharmacol Sci; 2016 Oct; 37(10):843-857. PubMed ID: 27461952
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
Jadamba E; Shin M
Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
[TBL] [Abstract][Full Text] [Related]
14. PATHOME-Drug: a subpathway-based polypharmacology drug-repositioning method.
Nam S; Lee S; Park S; Lee J; Park A; Kim YH; Park T
Bioinformatics; 2022 Jan; 38(2):444-452. PubMed ID: 34515762
[TBL] [Abstract][Full Text] [Related]
15. DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies.
Fu C; Jin G; Gao J; Zhu R; Ballesteros-Villagrana E; Wong ST
Bioinformatics; 2013 Jul; 29(14):1834-6. PubMed ID: 23681121
[TBL] [Abstract][Full Text] [Related]
16. Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases.
Williams K; Bilsland E; Sparkes A; Aubrey W; Young M; Soldatova LN; De Grave K; Ramon J; de Clare M; Sirawaraporn W; Oliver SG; King RD
J R Soc Interface; 2015 Mar; 12(104):20141289. PubMed ID: 25652463
[TBL] [Abstract][Full Text] [Related]
17. DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information.
Amelio I; Gostev M; Knight RA; Willis AE; Melino G; Antonov AV
Cell Death Dis; 2014 Feb; 5(2):e1051. PubMed ID: 24503543
[TBL] [Abstract][Full Text] [Related]
18. GREP: genome for REPositioning drugs.
Sakaue S; Okada Y
Bioinformatics; 2019 Oct; 35(19):3821-3823. PubMed ID: 30859178
[TBL] [Abstract][Full Text] [Related]
19. Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System.
Regan K; Moosavinasab S; Payne P; Lin S
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060329
[TBL] [Abstract][Full Text] [Related]
20. DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data.
Pacini C; Iorio F; Gonçalves E; Iskar M; Klabunde T; Bork P; Saez-Rodriguez J
Bioinformatics; 2013 Jan; 29(1):132-4. PubMed ID: 23129297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
